paclitaxel liposome - Globe Thesis

Keyword [paclitaxel liposome] Result: 21 - 35 \| Page: 2 of 2
21.	Comparison Of Efficacy And Safety For TF Regimen Or XELOX Regimen As Postoperative Adjuvant Treatment In Gastic Cancer
22.	Compared Efficacy Between Paclitaxel Liposome Combined With Modified FOLFOX6 And S-1 Regimen For Recurrent Patients With Postoperative Gastric Cancer
23.	Inhibition Of Akt/GSK3? Activation By Liposomes Loading Paclitaxel-Cholesterol Complexes In The Treatment Of Keloid
24.	Network Meta-analysis Of The Clinical Treatment Of Cancer With Paclitaxel Drug Delivery System
25.	Comparative Study Of Different Treatment Schemes For Advanced Lung Adenocarcinoma With Poor Physical Condition-single Drug Pemetrexed, Paclitaxel Liposome And The Best Supportive Care
26.	Study On The Preparation Of Paclitaxel Proliposomes And Its Pharmacokinetics By Oral Administration
27.	Inhalable Chemotherapy Drugs And Bacterial Preparations For The Treatment Of Primary Lung Cancer
28.	The Correlation Between Plasma Concentration And Adverse Reactions,efficacy In Patients With Gynecologic Tumor After Paclitaxel Liposome-based Chemotherapy
29.	Efficacy And Safety Of Liposome-Paclitaxel/Liposome-Paclitaxel Combined With S-1 In Advanced Gastric Cancer Patients With Poor Performance Status
30.	A Novel Bibranched Fructose Modified Liposome For Paclitaxel Delivery In Breast Cancer Therapy
31.	Analysis Of The Changes Of TCM Syndromes And Syndrome Types Before And After Chemotherapy With Paclitaxel Liposome And Nedaplatin In Advanced Esophageal Cancer
32.	Clinical Effect And Prognostic Factors Analysis Of Paclitaxel Liposome Combined Cisplatin For Advanced Esophageal Squamous Cell Carcinoma
33.	Cancer Cell Membrane Hybrid Liposome-loading Paclitaxel Targeted Treatment Of Melanoma
34.	The Efficacy Of Chemotherapy And Immunotherapy For Patients With Advanced Gastric Cancer And Colorectal Cancer And The Analyses Of Prognostic Factors
35.	To Explore The Clinical Efficacy Of Paclitaxel Liposome And Nedaplatin In The Treatment Of Advanced Esophageal Carcinoma And The Clinical Characteristics Of Liver Dysfunction During The Treatment Of Combination Of Camrelizumab And Apatinib
<<First <Prev Next> Last>> Jump to